Many DexCom, Inc.(DXCM) Stock Research Financial Advisors from Investment Banking firms have advised their client and investors on the stock. DexCom was Downgraded by Morgan Stanley on Jan 3, 2017 to Equal-Weight, Price Target of the shares are set at $66.DexCom was Upgraded by Oppenheimer to Outperform on Dec 19, 2016.
Company has reported several Insider transactions to the SEC, on Feb 13, 2017, John Lister (General Manager, EMEA) sold 3,000 shares at 79.74 per share price.On Feb 13, 2017, Jorge A Valdes (CTO) sold 7,000 shares at 79.76 per share price.On Jan 25, 2017, Richard Doubleday (EVP, Chief Commercial Officer) sold 3,182 shares at 79.50 per share price.
DexCom Last issued its quarterly earnings results on Nov 1, 2016. The company reported $-0.07 EPS for the quarter, beating the analyst consensus estimate by $ 0.06. Analyst had a consensus of $-0.13. The company had revenue of $148.60 million for the quarter, compared to analysts expectations of $146.63 million. The companys revenue was up 41.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted $-0.07 EPS.
DexCom, Inc. (NASDAQ:DXCM) has received a short term rating of hold from experts at Zacks with a rank of 3. The stock has been rated an average of 1.56 by 16 Brokerage Firm. 12 Wall Street Firms have rated the stock as a strong buys. 1 stock experts have also suggested a buy rating. 2 Brokerage Firms have advised hold. 1 Analysts have rated it as strong sell.
DexCom, Inc. (NASDAQ:DXCM) stock has received a short term price target of $ 85.31 from 16 Analyst. The share price can be expected to fluctuate from the mean short term target, can be seen from the standard deviation reading of $13.27. The higher estimate of target price is $106 , while the lower price target estimate is $59
DexCom, Inc. (NASDAQ:DXCM) rose 1.05% or 0.84 points on Tuesday and made its way into the gainers of the day. After trading began at $80.5 the stock was seen hitting $81.36 as a peak level and $79.55 as the lowest level. The stock ended up at $81.06. The daily volume was measured at 1,063,456 shares. The 52-week high of the share price is $96.38 and the 52-week low is $56.12. The company has a market cap of $6,852 million.
Dexcom Inc. is developing continuous glucose monitoring systems for people with diabetes.